$69.62
+0.44 (+0.64%)
Performance
1D
—
1W
—
1M
—
3M
+36.30%
6M
+79.25%
1Y
+176.71%
YTD
+66.59%
Open$68.90
Previous Close$69.18
Day High$70.32
Day Low$68.55
52W High$73.56
52W Low$21.00
Volume—
Avg Volume672.3K
Market Cap5.84B
P/E Ratio—
EPS$-2.08
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.74
Above
SMA 200
$36.07
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-48.4% upside
Current
$69.62
$69.62
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.39M | 3.43M | 1.61B |
| Net Income | -174,733,415 | -239,151,834 | -285,460,132 |
| Profit Margin | -3,985.0% | -7,343.0% | -17.7% |
| EBITDA | -205,651,145 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | +176.6% | -52.1% | +15.2% |
| Debt/Equity | 0.00 | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |